11th Annual Outsourcing in Clinical Trials UK and Ireland 2024

Welcome to 11th annual Outsourcing in Clinical Trials UK and Ireland 2024

11 - 12

June

2024
  • London Hilton on Park Lane, UK
  • Complimentary
  • Why attend?
  • Agenda
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • Sponsors
  • Media Centre
  • Why partner?
  • Resources
  • Contact Us
close

Featured Speakers

Back

Lord James O’Shaughnessy​

Member of the House of Lords, former Health Minister, Senior Partner at Newmarket Strategy

James has operated at the highest levels of government, including as a Minister at the
Department for Health & Social Care, as Director of the No.10 Policy Unit, and as an advisor to
DHSC Ministers during the COVID-19 crisis. As Minister his responsibilities included
implementing the Life Science Industrial Strategy, delivering a new pricing scheme with the
pharmaceutical industry, chairing the National Genomics Board, and driving the digital
transformation of the NHS. He was also responsible for preparing the health and social care
sectors for Brexit and helping to design the post-Brexit regulatory regime.

James is co-founder and Senior Partner of Newmarket Strategy, a consultancy dedicated to
improving access to health innovation by providing strategic advice and technical support to
the healthcare, life sciences and health tech sectors. He is also a non-executive director at
HDR-UK and the Albion Development VCT plc. In early 2023 James was commissioned by the
Government to carry out an independent review of commercial clinical trials in the UK, which
was published in May.

 

Next speaker
Back

Farrell Healion​

Senior Director, Emerging Technology, Global Clinical Solutions, AstraZeneca

Farrell Healion is currently Senior Director Emerging Technologies, Global Clinical Solutions at AstraZeneca, where he leads the operational readiness delivery to scale up new technologies to be used in their clinical trials. He previously led their Digital Patient Solutions team that deliver patient-facing Digital Health Technologies(DHTs) such as eCOA across the AstraZeneca portfolio.

Starting out as an eCOA Developer at CRF Health, Farrell then moved through various technical leadership roles eventually leading the Technical and Project Management Office in Signant Health before moving to AstraZeneca. He is passionate about scaling up the use of patient and site-centric new DHTs in Clinical Trials, getting involved with various industry work groups such as DTRA and the eCOA Consortium. He is also the 2023 winner in Pharmatimes International Clinical Researcher of the Year award in the Decentralised Solutions category.

 

Next speaker
Back

Craig Elliott​

Director Alliance Management and Sourcing, Merck

Craig is Director Alliance Management and Sourcing, with responsibility for Central Labs, Imaging, Phase 1 and Early Access Programs.

Craig has worked for over 35 years in Clinical Research in both large pharma and small, medium and large CROs and academia performing a number of roles: CRA, line management, quality and training, alliance management, process improvement and strategic improvements. Craig has worked across multiple therapeutic areas and supported business development and operations interacting with large pharmaceutical companies and biotech sponsors.  He has worked on a number of global strategic initiatives.

Craig is a PhD in Respiratory and Exercise Physiology and a BSc in Physiology and Biology.  He is also a qualified cricket coach.

Next speaker
Back

Ashton Harper​

Head of Medical Affairs, Access & Innovation, Roche

Next speaker
Back

Michael Lewis​

Professor of Life Science Innovation, University of Birmingham and Scientific Director Innovation, NIHR

Next speaker
Back

Alecia Barry​

Alecia Barry, Executive Director, Oncology Clinical Operations, Gilead Sciences

Alecia Barry, PhD, joined Gilead in 2022 as Clinical Operations Franchise Head for Breast, Gynaecological and Genito-urinary Cancers.   In her current role, Alecia oversees and leads a large group of oncology Clinical Operations professionals with global scope and accountability for operational strategy definition and trial execution to meet cost, speed and quality standards.  Alecia serves a thought partner to the Oncology Clinical Development Franchise Heads providing strategic operational leadership and expertise. She is a member of the Clinical Operations Oncology Leadership Team with responsibilities for developing and evolving short- and long-range Clinical Operations strategies, plans, processes, tools and infrastructure development. Alecia functions as a Clinical Operations Vendor Lead for strategic CRO partnerships, with accountability to develop relationships, identify cross-portfolio issues, elevate to governance committees, and lead effective multi-level engagement and communication with Gilead and with CRO partners.

Alecia obtained her pharmacy degree, higher diploma in Quality Management and a PhD in Pharmaceutics from Trinity College, University of Dublin.  Alecia has more than 15 years’ experience in the pharmaceutical industry across at various levels and positions in pharmaceutical development and clinical operations.

Next speaker

    Sponsors Include:

    Back

    Company Information

    EMIS Recruit is an integrated solution that connects Research, Life Sciences and healthcare by embedding clinical research recruitment tools directly into the point of care systems.  EMIS recruit gives research organisations clear visibility of clinically relevant patients based on your study protocol. This enables us to provide you with qualified patients that streamline your recruitment process

    Next Sponsor
    Back

    Company Information

    Simply sourcing comparators – we offer a unique blend of small company flexibility and speed, backed with the large-scale buying power of the Orifarm Group, which is one of the largest pharmaceutical suppliers in Europe. With over €1.4B products sold in 2021 and more than 4,000 unique product lines sourced on a monthly basis, we have unparalleled access to “out of market” and manufacturer direct buying capability, both in the US and Europe.

    Company website: www.Orifarm-CTS.com

    Company Website

    To learn more, please visit our website - www.Orifarm-CTS.com

    Next Sponsor
    Back

    Company Information

    Imagine a paediatric-specific engagement platform, fully co-designed with children and child life specialists. The Little Journey app helps to reduce anxiety before, during and after paediatric clinical trial visits by educating and preparing children and families using engaging, age-tailored personalised multimedia that can be accessed anywhere at any time.

    Company Website

    To learn more, please visit our website - https://www.littlejourney.health/

    Next Sponsor
    Back

    Company Information

    Cytel Inc. www.cytel.com is a leading provider of clinical research services and trial design and analysis software primarily for the biopharmaceutical and medical device development markets.

    Cytel pioneered the statistical and computational science of adaptive clinical trials and has designed more validated adaptive trials than any other service provider.

    Company Website

    To learn more, please visit our website - http://www.cytel.com

    Next Sponsor
    Back

    Company Information

    Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com. 

    Company Website

    To learn more, please visit our website - www.SyneosHealth.com

    Next Sponsor
    Back

    Company Information

    Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 35,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

    Company Website

    To learn more, please visit our website - https://www.medidata.com

    Next Sponsor
    Back

    Company Information

    Founded in 2015 Teckro provides solutions to simplify and modernize clinical research for leading pharmaceutical and emerging biotech companies. To date, Teckro manages more than 100 clinical trials and is used by more than 11,800 active study sites around the world. Teckro employs more than 100 staff across its global headquarters in Limerick, Ireland, engineering excellence hub in Dublin, Ireland and its US-based office in Nashville, Tennessee. Visit www.teckro.com for more information.

     

    Company Website

    To learn more, please visit our website - http://www.teckro.com/

    Next Sponsor
    Back

    Company Information

    Medicover Integrated Clinical Services is a unique clinical research organization with 25 years of experience.

    We offer Patient Recruitment services through our own Clinical Research Network in Central and Eastern Europe with comprehensive Global Central Lab Services and access to over 8,000 tests from routine to advanced diagnostics including genetics, biomarkers, PK and PD, and PBMC isolation in more than 120 laboratories in Europe and India.

    Company Website

    To learn more, please visit our website - https://medicover-mics.com/

    Next Sponsor
    Back

    Company Information

    Optimapharm is a globally operating, leading, mid-sized, full-service CRO aiming to deliver new therapies to improve and save patients’ lives.
    With 26 strategically located offices, Optimapharm is giving unrivalled access to Patients and Investigators worldwide.
    Optimapharm conducts phase I – IV studies in all therapeutic areas. With very strong operational teams, Optimapharm has a reputation for excellence delivery in all projects, including rescue studies.

    Company Website

    To learn more, please visit our website - https://optimapharm.eu/

    Next Sponsor
    Back

    Company Information

    Greenphire is the industry leader of clinical payment technology, designed to improve the way research professionals work. We leverage our proprietary payments platform and workflow automation to help clients improve operational efficiency, reduce costs, mitigate regulatory risks, improve the patient and site experience and produce quantifiable results that improve clinical operations and strategic planning.

    Company Website

    To learn more, please visit our website - http://greenphire.com/

    Next Sponsor
    Back

    Company Information

    ESMS Global provides specialist support related to Clinical Trials and Medical Information. Our services include a Global Emergency Unblinding Service, Clinical Trials Direct to Patient Helpline, Serious Breach Reporting Service, and a Medical Information Helpline, all available 24/7, across the globe, in 45 languages.

    Company Website

    To learn more, please visit our website - www.esmsglobal.com

    Next Sponsor
    Back

    Company Information

    At Trilogy, medical writing is our passion. As specialists in clinical regulatory documentation, we provide a service that is more than just writing. We proactively plan, coordinate and write clinical documents to meet timelines, with a readability that reduces the time for review and approval.

    Company Website

    To learn more, please visit our website - https://www.trilogywriting.com/

    Next Sponsor
    Back

    Company Information

    TFS HealthScience is a global Contract Research Organization (CRO) partnering with biotechnology and pharmaceutical companies throughout their entire clinical development journey. Bringing together nearly 700 professionals, we deliver tailored clinical research services in more than 40 countries. TFS supports customers with comprehensive solutions including full clinical development services, strategic and flexible resourcing. In partnership, we build solution-driven teams of experienced professionals working together for a healthier future. Our mission is to bring treatments to patients faster. For more information, please visit www.tfscro.com.

    Company Website

    To learn more, please visit our website - www.tfscro.com.

    Next Sponsor
    Back

    Company Website

    To learn more, please visit our website - http://www.medpace.com/

    Next Sponsor
    Back

    Company Information

    The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.

    Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

    The international company is a privately owned organisation which has grown organically over the past five decades now employing over 5,600 highly skilled personnel across 18 facilities including Europe, the US and Asia.

    The company has a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.

    To keep up to date with latest news, follow Almac Group on Twitter and LinkedIn or visit almacgroup.com.

    Company Website

    To learn more, please visit our website - https://www.almacgroup.com

    Next Sponsor
    Back

    Company Information

    At Viedoc, we design engaging software that modernizes clinical research so that necessary treatments can reach the people who need them faster. We believe in life and science, in people, and in our collective power to change the world and build a healthier future. That unmatched driving force is what pushes us to innovate, accelerate and improve every aspect of modern clinical studies.

    Company Website

    To learn more, please visit our website - www.viedoc.com

    Next Sponsor
    Back

    Company Information

    Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company’s Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,000 trials across 80 countries.

    Company Website

    To learn more, please visit our website - https://www.suvoda.com/

    Next Sponsor
    Back

    Company Information

    ClinChoice is a leading full-service clinical CRO offering high-quality solutions to pharmaceutical, biotechnology, medical device and consumer products clients. We contribute to a safer and better world by helping our sponsor clients accelerate drug and device approvals to market. We do this by combining our 25 years of proven quality and results with expertise in 30+ therapeutic areas, a flexible approach, and dedicated teams who enable rapid startups and fast timelines.

    Next Sponsor
    Back

    Company Information

    CMIC Group, founded as Japan’s first CRO over 30 years ago, is now the largest clinical CRO in Japan with a global presence. Our services span non-clinical studies, clinical trial management, GMP manufacturing, regulatory consulting, and sales/marketing solutions. We facilitate market entry in Japan, offer leading clinical trial expertise in APAC region, and bridge drug development between the US and Japan. With 7,000+ employees and 24 global sites, we’re your comprehensive partner in the pharmaceutical, biotech, and medical device sectors.

    Company Website

    To learn more, please visit our website - https://en.cmicgroup.com/

    Next Sponsor
    Back

    Company Information

    B. Braun specialises in manufacturing market leading infusion therapy products, many of which are supplied into clinical trials. With presence in over 64 countries around the world, we work closely with our partners to select solutions that fit with the individual clinical trial requirements.

    For more information, please visit:

    Company Website

    To learn more, please visit our website - bbraun.co.uk/en/products-and-therapies/bbraun-industrial-business.html

    Next Sponsor

      Why attend?

      We are delighted to welcome you to 11th annual Outsourcing in Clinical Trials UK and Ireland.

      This is a great opportunity to get together and network face to face, hear from our expert speaker line-up and discuss the latest innovations and regulatory updates in the industry.

      This exclusive event brings together attendees from established pharma, large and small, alongside biopharmaceutical companies and gives opportunity to dive into the operational challenges and innovations in clinical development found within the UK & Ireland region.

      This year will also focus on government initiatives for UK growth and opportunities within the clinical trial landscape.

      We look forward to you joining us!

      WHAT TO EXPECT FOR 2024?

      This exclusive event brings together attendees from established pharma, large and small, alongside with biopharmaceutical companies and gives opportunity to dive into the operational challenges and innovations in clinical development found within the UK & Ireland region.

      200+

      Attendees

      		50+

      Exhibitors

      		40+

      Speakers
      200+

      Attendees

      		50+

      Exhibitors
      40+

      Speakers

      Testimonials

      See What It's All About

      Agenda

      • 11 Jun 2024
      • 12 Jun 2024
      Expand All

      Streams

      Stream one

      STREAM A: Clinical Operations and Outsourcing

      Stream two

      STREAM B: Clinical Technology and Innovation

      11:15 AM

      Morning refreshments and networking

      11:45 AM

      Case study: Redefining clinical data flow

      Sharing experiences from a holistic change of systems and processes including: data collection, data standardization, flow into AstraZeneca, data management, medical and safety review, data analysis and reporting, and long term data retention

      Speakers

      Lucy Moore
      Executive Director, Clinical Data Projects, Clinical Data and Insights, AstraZeneca

      12:15 PM

      A 360° view of digitalization in clinical trials

      • Presenting on how to digitalize clinical trials in e.g. endpoints, and study designs
      • Highlighting the possibilities that digital trials bring, whilst moving away from the common brick-and-mortar sites
      • Discussing the rigorous standards and scientific integrity required by regulators, whether a regular brick-and-mortar trial or a digital trial
      • How we tend to focus too much on technology when it's actually the processes for the patients and the sites that matter even more
      • Major points to consider in designing digital trials; building blocks and practical examples to best prepare you to meet the needs of regulators whilst keeping the patients and sites front of mind

      Speakers

      Sverre Bengtsson
      Co-Founder, Viedoc

      12:45 PM

      Artificial Intelligence in Pharma

      • Brief overview of AI/GenAI market, including current limitations and technology roadmap
      • AI and its applications in Healthcare, from business processes to use cases
      • Models to acquire GenAI capabilities
      • GenAI delivery models
      • Risks, costs and other considerations

      Speakers

      Josep Bori
      Research Director, Thematics Division, GlobalData

      1:15 PM

      Lunch and networking

      2:15 PM

      Putting patients at the centre of their clinical trial journey: supporting engagement, driving ePRO compliance

      • How robust, globally-deployable solutions can be designed from a 'patient-first' perspective
      • Sharing learning on achieving meaningful engagement throughout the study
      • Exploring how modern technology both retains patients and drives high eCOA/ePRO compliance
      • Case studies on embedding human-centred design to deliver faster, more flexible outcomes for sponsors

      Speakers

      Bruce Hellman
      Co-Founder and Chief Patient Officer, UMotif

      2:45 PM

      Vaccine Trial – what we have learnt and what could be used more widely?

      • Brief overview of innovations used to improve the set-up and performance of vaccine studies
      • Focus on innovations that could be more widely utilised for:
        • Investigators
        • Sites
        • Placement
        • Recruitment
        • Set-up & Agreements

      Speakers

      Andrew Ustianowski
      Network Director, upcoming North West Regional Research Delivery Network, NIHR

      3:15 PM

      Afternoon break, networking and prize draw

      3:45 PM

      Fireside Chat: Exploring data management tools and technologies that can assist in clinical trials

      • Discussing technologies and tools available for use in clinical trial
      • Outlining the risks and rewards of data management tools and technologies
      • Explaining how to implement: providing examples of successes and lessons learnt

      Speakers

      Lucy Moore
      Executive Director, Clinical Data Projects, Clinical Data and Insights, AstraZeneca
      Richard Gray
      Managing Partner, Medidata, Dassault Systemes

      8 AM

      Registration and refreshments

      8:50 AM

      Chairperson’s opening remarks

      Speakers

      Priya Ravisekara
      Senior Analyst, GlobalData

      9 AM

      Keynote: Latest overview of UK clinical trial landscape: are we achieving the ambition?

      • Progression so far since the clinical trial review
      • Further improvements and plans to achieve them
      • Outlook for the future of UK clinical trials

      Presented by Michael Lewis, due to Purdah, on behalf of  Prof Lucy Chappell

      Speakers

      Professor Lucy Chappell
      Chief Scientific Adviser, Department of Health and Social Care
      Michael Lewis
      Professor of Life Science Innovation, University of Birmingham and Scientific Director Innovation, NIHR

      9:30 AM

      Panel discussion and audience Q&A: Reviewing recent improvements to UK clinical trial landscape and future actions for continued success

      • Discussing positive progress made in the UK since the clinical trial review in May 2023
      • Considering ongoing challenges and future actions required
      • Hearing viewpoints on where we are now from experience on the ground

       

      Michael Lewis as panelist, on behalf of  Prof Lucy Chappell due to Purdah

      Speakers

      Lord James O’Shaughnessy
      Member of the House of Lords, former Health Minister, Senior Partner at Newmarket Strategy
      Andrew Ustianowski
      Network Director, upcoming North West Regional Research Delivery Network, NIHR
      Janet Valentine
      Executive Director Innovation and Research Policy, ABPI
      Professor Lucy Chappell
      Chief Scientific Adviser, Department of Health and Social Care
      Michael Lewis
      Professor of Life Science Innovation, University of Birmingham and Scientific Director Innovation, NIHR

      10:15 AM

      A New Paradigm for Clinical Innovation

      The clinical research industry is at an inflection point. Advancements in technology have created the opportunity to transform clinical trial outcomes, but to make this ambition a reality, we must now rethink how we engage with patients. Today, we often treat patient relationships as transactional, de-identified numbers on individual clinical trials. We need a new way of thinking about patients. A more longitudinal way, with greater pre-trial engagement and post-trial follow-up, and across multiple studies and healthcare experiences. We also need to change how we look at patient data, widening the lens to understand patients’ health and research journeys across a broad ecosystem of data sources. But how do we execute this paradigm shift when we’re also under pressure to accelerate timelines, reduce risk, lower costs, and improve quality?

      In this presentation, we’ll explore:

      • Industry drivers of this clinical research evolution
      • Challenges faced & the value of change
      • Reasons to believe - Improving trial experiences for patients, sites, CROs, & sponsors

      Speakers

      Richard Gray
      Managing Partner, Medidata, Dassault Systemes

      10:45 AM

      Partnering with primary care to maximise study site potential

      Insufficient patient recruitment for clinical trials can strain resources and prolong study timelines. By tapping into a large pool of quality candidates, you can ensure your proposed study sites are working optimally and avoid the need to open additional sites.

      Join this session to learn how partnering with GP practices through their primary care clinical system can enable you to reach a huge number of patients that were previously inaccessible. By integrating Electronic Health Records (EHRs) with proactive engagement from primary care teams, study sites can quickly recruit from a wider patient pool and reach previously untapped demographics.

      Speakers

      Mihad Mohamed
      Product Director – Research and Life Sciences, EMIS

      11:15 AM

      Morning refreshments and networking

      11:45 AM

      Finding the right balance between the needs of sponsor company and vendor for successful partnerships and oversight

      • Integrating vendors and silos into your own organization
      • Where does vendor management end and vendor oversight start?
      • Creating the right framework for a long-lasting partnership

      Speakers

      Craig Elliott
      Director Alliance Management and Sourcing, Merck

      12:15 PM

      Re-defining the sponsor and hospital site relationship in 2024

      • Leveraging site relationships to deliver your study to time and target
      • Motivating your sites to improve performance
      • Improving your understanding of site process to better plan your study

      Speakers

      Davy Yeung
      COO, TCR-Solutions

      12:45 PM

      Incorporating sustainability in clinical trials to improve ESG responsibilities

      • Healthcare sector’s responsibility and action to address the climate crisis as accelerator for the health crisis
      • Methodology and available tools to assess carbon footprint of clinical trials
      • Clinical best-practices to save significant natural and financial resources
      • Incorporating sustainability endpoints into clinical trials

      Speakers

      Ashton Harper
      Head of Medical Affairs, Access & Innovation, Roche

      1:15 PM

      Lunch and networking

      2:15 PM

      Unlocking APAC potential to enhance your Clinical Trial Program

      • Understanding how site capabilities, regional infrastructure and a favorable regulatory environment in Asia-Pacific can expedite enrolment in your clinical trials
      • R&D incentive schemes and the positive impact on the costs of your early phase studies
      • Regional trends to access advanced healthcare technologies and innovations in Asia-Pacific

      Speakers

      Yooni Kim
      Vice President Clinical Services, Novotech

      2:45 PM

      Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

      • Finding the right balance between the needs of sponsor company and vendor to ensure right fit
      • Negotiating contracts: costs vs vendor ability to perform
      • Forging partnerships and relationships to enhance contract negotiations and communication

      Speakers

      Priya Ravisekara
      Senior Analyst, GlobalData
      Rachael McTegart
      Contracts and Outsourcing Director, Barinthus Biotherapeutics
      Craig Elliott
      Director Alliance Management and Sourcing, Merck
      Leonie Martin
      Senior Director, Clinical Operations, Orchard Therapeutics
      Evelyne Newton
      Vice President of Business Development, Velocity Clinical Research

      3:15 PM

      Afternoon refreshments, networking and prize draw

      3:45 PM

      Panel discussion: Overcoming site start-up delays and maximizing site productivity

      • Managing timelines for CTA sign off to avoid bottlenecks
      • Aligning team involvement for responsibilities and oversight
      • Addressing current challenges sites are facing

      Speakers

      Priya Ravisekara
      Senior Analyst, GlobalData
      Fiona Shields
      Study and Site Operations Country Head (UK), Novartis
      Yinka Cole
      Associate Director, Clinical Data and Site Operations, Adaptimmune
      Andrew Ustianowski
      Network Director, upcoming North West Regional Research Delivery Network, NIHR
      Sevtap Rowlands
      Director of Clinical Operations, 4 Medical Clinical Solutions (4MCS)

      4:30 PM

      Chairperson’s closing remarks

      Speakers

      Priya Ravisekara
      Senior Analyst, GlobalData

      4:35 PM

      END OF DAY 1 AND NETWORKING DRINKS RECEPTION

      Streams

      Stream one

      STREAM A: Clinical Operations and Outsourcing

      Stream two

      STREAM B: Clinical Technology and Innovation

      11:45 AM

      Implementing digital health technologies into clinical trials

      • What is Digital Health?
      • How can Digital Health Technologies be used in Clinical Development?
      • Challenges and opportunities
      • Process for selection and implementation

      Speakers

      Farrell Healion
      Senior Director, Emerging Technology, Global Clinical Solutions, AstraZeneca

      12:15 PM

      Panel Discussion: Innovative thinking for increasing patient diversity and inclusion in clinical trials

      Whilst diversity has been a hot topic for some time, it remains of key importance to improve in the UK

      • Ensuring diversity in medical research: how are we progressing?
      • Increasing diversity in clinical trial patient recruitment
      • Advancing medicine through increased diversity

      Speakers

      Ken Chow
      Health Tech Counsel, Flanders Investment & Trade
      Sarah Tissington
      Regional Director, Clinical Site Management & Monitoring EU/UK, Moderna
      Shilpa Muthusamy
      Principle Investigator and Site Director, Velocity Clinical Research

      12:45 PM

      Lunch and networking

      8 AM

      Registration and refreshments

      8:50 AM

      Chairperson’s opening remarks

      Speakers

      Priya Ravisekara
      Senior Analyst, GlobalData

      9 AM

      Keynote: Clinical trial review – one year on, where are we now?

      In May 2023, Lord James O’Shaughnessy published an independent review of commercial clinical trials in the UK, commissioned by the Government. Since the review, the UK have been responding to action his recommendations on how commercial clinical trials can help the life sciences sector unlock UK growth and investment opportunities and resolve key challenges in conducting commercial clinical trials in the UK. Lord James O’Shaughnessy returns this year to provide an update on where the UK are at, one year on since his review.

      Speakers

      Lord James O’Shaughnessy
      Member of the House of Lords, former Health Minister, Senior Partner at Newmarket Strategy

      9:30 AM

      How RBQM creates trust between sponsors and CROs

      • The big communication and trust challenges we see from hundreds of projects
      • What do the ultimate customers (regulatory authorities) want to see?
      • What is RBQM, what are the challenges, and how can it help?
      • How technology makes all the difference

      Speakers

      Duncan Hall
      Chief Executive Officer, TRI

      10 AM

      Fireside Chat: The patient journey when participating in a clinical trial

      • What do patients experience when participating in a clinical trial from start to finish?
      • Understanding patients’ motivations for choosing and staying in a clinical trial
      • Hurdles and barriers to patients’ participation in clinical trials: what can companies do to improve this and relieve burden on patients?
      • How can technology both help and hinder patients’ engagement in clinical trials?

      Speakers

      Rebecca Mbewe
      Patient Advocate

      10:30 AM

      An evolution of the clinical trial site

      • A comprehensive overview of traditional clinical trial management, highlighting the pros and cons of conventional research site
      • Understanding the burden trial sites face and the necessity for clinical trial sites to evolve and expand their reach and services
      • A review of site-facing technology, patient-centric approaches, and patient diversity
      • Understanding what sponsors require from research partners and the role of sites within that paradigm
      • An exploration of VCTC's approach to clinical trials as a non-traditional site
      • Delivering highly flexible trials including onsite to virtual elements and everything in between

      Speakers

      Helen Shaw
      Head of Clinical Operations and Co-Founder, VCTC

      11 AM

      Morning refreshments and networking

      11:45 AM

      Clinical trial budgeting – is the price right?

      • Tackling the growing variance between forecasted and actual clinical trial cost due to headwinds of ballooning R&D costs, increasing study complexity and global uncertainty
      • Delivering a win-win for patients and study budget through patient-centric trial design

      Speakers

      Alecia Barry
      Alecia Barry, Executive Director, Oncology Clinical Operations, Gilead Sciences

      12:15 PM

      Clinical trials: Adoptive cell therapy

      • Adoptive Cell Therapy Trials Overview and Comparison to UK performance
      • Active Companies in Adoptive Cell Therapy
      • Adoptive Cell Therapy Trials in Q1 2024
      • Upcoming Adoptive Cell Therapy Trials

      Speakers

      Scotty Chung-Siu
      Managing Analyst, Clinical Trials Intelligence, GlobalData

      12:45 PM

      Lunch and networking

      2 PM

      Case study: Utilising academic and industry collaborations for PPI in clinical trials

      • Overview of the drug used in the clinical trial
      • Integrating and increasing PPI through academic and industry collaboration
      • Highlighting the value of PPI on trial design, recruitment and retainment

      Speakers

      Julia DeCesare
      Senior Director, Clinical Operations, Accession Therapeutics
      Dave Cole
      Head of Research, Accession Therapeutics
      Julie Hepburn
      Patient Representative Lead PPI&E, Cardiff ECMC and Advanced Therapies Wales

      2:30 PM

      Utilising remote sampling in large studies: examples and key learnings

      • Examples of published clinical trials using remote sampling approaches and key learnings from these
      • Use of remote VAMS sampling to measure toxic chemicals for epidemiological and related studies, why handwashing is so important
      • Using dried remote samples for sample collection in a large European project for studying Psoriatic Arthritis

      Speakers

      James Rudge
      Technical Director, Neoteryx

      3 PM

      Afternoon refreshments, networking, and Apple Prize Draw

      3:30 PM

      ROUNDTABLE SESSIONS

      During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table lead/host and will focus on a different challenge within the industry. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice

      ROUNDTABLE 1
      Re-evaluating study if things go wrong with CRO or country in clinical trial: to stay or change?
      Alison McMorn, VP Clinical Development, AMO Pharma

      ROUNDTABLE 2
      Considerations for cell and gene therapy trials set up
      Yinka Cole, Associate Director, Clinical Data and Site Operations, Adaptimmune

      ROUNDTABLE 3
      Navigating the Complexities of Radiopharmaceutical Therapy (RPT) Clinical Trials
      Nathaniel Scott, Medical Physicist, Blue Earth Therapeutics

      Speakers

      Dr Alison McMorn
      PH.D – VP, CLINICAL DEVELOPMENT, AMO PHARMA LTD
      Yinka Cole
      Associate Director, Clinical Data and Site Operations, Adaptimmune
      Nathaniel Scott
      Medical Physicist, Blue Earth Therapeutics

      4:30 PM

      Chairperson’s closing remarks

      Speakers

      Priya Ravisekara
      Senior Analyst, GlobalData

      END OF CONFERENCE

      Speakers

      Select a speaker to learn more

      Back
      Lord James O’Shaughnessy
      Member of the House of Lords, former Health Minister, Senior Partner at Newmarket Strategy

      James has operated at the highest levels of government, including as a Minister at the
      Department for Health & Social Care, as Director of the No.10 Policy Unit, and as an advisor to
      DHSC Ministers during the COVID-19 crisis. As Minister his responsibilities included
      implementing the Life Science Industrial Strategy, delivering a new pricing scheme with the
      pharmaceutical industry, chairing the National Genomics Board, and driving the digital
      transformation of the NHS. He was also responsible for preparing the health and social care
      sectors for Brexit and helping to design the post-Brexit regulatory regime.

      James is co-founder and Senior Partner of Newmarket Strategy, a consultancy dedicated to
      improving access to health innovation by providing strategic advice and technical support to
      the healthcare, life sciences and health tech sectors. He is also a non-executive director at
      HDR-UK and the Albion Development VCT plc. In early 2023 James was commissioned by the
      Government to carry out an independent review of commercial clinical trials in the UK, which
      was published in May.

       

      Session Details:

      Panel discussion and audience Q&A: Reviewing recent improvements to UK clinical trial landscape and future actions for continued success

      2024-06-11, 9:30 AM

      Session Details:

      Keynote: Clinical trial review – one year on, where are we now?

      2024-06-12, 9:00 AM

      View In Agenda
      Next speaker
      Back
      Andrew Ustianowski
      Network Director, upcoming North West Regional Research Delivery Network, NIHR

      Professor Andrew Ustianowski is a Consultant Physician in Infectious Diseases at the Regional Infection Unit, North Manchester General Hospital, UK, and from April 2024 the Network Director for the NW Regional Research Delivery Network, National Institute of Health Research (NIHR). Other roles include: the joint National Specialty Lead for Infection (NIHR); co-Clinical Director for the Greater Manchester Clinical Research Network; Clinical Lead for the Manchester Academic Health Science Centre; National Clinical Lead for the UK NIHR COVID Vaccine Research Programme; and joint National Clinical Lead for the UK’s Vaccine Innovation Pathway. He has been UK chief investigator on multiple COVID, HIV and other studies and PI on >100 other trials.

      Prof Ustianowski graduated from Guy’s Hospital, London, UK and subsequently trained in Infectious Diseases, Tropical Medicine, HIV and General Medicine in the London region

      Session Details:

      Panel discussion and audience Q&A: Reviewing recent improvements to UK clinical trial landscape and future actions for continued success

      2024-06-11, 9:30 AM

      Session Details:

      Panel discussion: Overcoming site start-up delays and maximizing site productivity

      2024-06-11, 3:45 PM

      Session Details:

      Vaccine Trial – what we have learnt and what could be used more widely?

      2024-06-11, 2:45 PM

      View In Agenda
      Next speaker
      Back
      Janet Valentine
      Executive Director Innovation and Research Policy, ABPI

      Janet has extensive experience in strategic leadership positions in the UK health research and health data research environment. As Executive Director of Innovation and Research Policy at the Association of the British Pharmaceutical Industry (ABPI), Janet is responsible for influencing Government policy to make the UK a globally attractive destination to discover and develop new medicines and vaccines. Janet was initially appointed to the ABPI as Director of Health Data and Digital Policy. Prior to joining the ABPI, Janet was the Industrial Strategy Challenge Fund Director for Data to Early Diagnosis and Precision Medicine at Innovate UK, where she oversaw a broad portfolio of investments in genomics, health data, AI, medical imaging and digital pathology. In her previous role as an Executive Director at the Medicines and Healthcare Products Regulatory Agency (MHRA), Janet led the Clinical Practice Research Datalink (CPRD). CPRD is the UK’s largest dedicated health data research service, providing research data services to industry, academia and regulators worldwide. Janet’s previous roles include Head of Population Health and Health Informatics at the Medical Research Council and Deputy Chief Executive of the UK Clinical Research Collaboration. Janet’s scientific background is in gene regulation.

      Session Details:

      Panel discussion and audience Q&A: Reviewing recent improvements to UK clinical trial landscape and future actions for continued success

      2024-06-11, 9:30 AM

      View In Agenda
      Next speaker
      Back
      Julia DeCesare
      Senior Director, Clinical Operations, Accession Therapeutics

      Session Details:

      Case study: Utilising academic and industry collaborations for PPI in clinical trials

      2024-06-12, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Dave Cole
      Head of Research, Accession Therapeutics

      Session Details:

      Case study: Utilising academic and industry collaborations for PPI in clinical trials

      2024-06-12, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Yinka Cole
      Associate Director, Clinical Data and Site Operations, Adaptimmune

      Session Details:

      Panel discussion: Overcoming site start-up delays and maximizing site productivity

      2024-06-11, 3:45 PM

      Session Details:

      ROUNDTABLE SESSIONS

      2024-06-12, 3:30 PM

      View In Agenda
      Next speaker
      Back
      Dr Alison McMorn
      PH.D – VP, CLINICAL DEVELOPMENT, AMO PHARMA LTD

      Dr. McMorn is an experienced clinical development researcher with over 25 years of industry experience and has a strong focus in CNS and paediatric drug development. She has worked for both Pharmaceutical Companies and Contract Research Organisations including holding positions at SAR Monitoring Services Ltd, Mundipharma International Ltd and Shire Development Inc. Starting her career at SAR as a Clinical Research Associate (CRA) she subsequently moved to Mundipharma where she was responsible for initiating the first paediatric clinical research program for the company. At Shire Dr. McMorn led, planned and managed global paediatric and adult clinical development programs for a wide variety of indications including psychiatry, pain, gastrointestinal and hepatology across all phases of development (Phase 0 to Phase 4). In addition she was responsible for harmonizing Clinical Trial Administrator (CTA) working practices across all regions for the company. In 2015 Dr. McMorn joined AMO Pharma Ltd, a virtual pharmaceutical company focused predominantly on paediatric neurodevelopmental rare diseases, as VP of Clinical Development. She holds an undergraduate degree in Pharmacology and a PhD in Psychology from the University of Leeds, UK.

      Session Details:

      ROUNDTABLE SESSIONS

      2024-06-12, 3:30 PM

      View In Agenda
      Next speaker
      Back
      Lucy Moore
      Executive Director, Clinical Data Projects, Clinical Data and Insights, AstraZeneca

      Lucy Moore has over twenty years of pharma industry experience, starting first as a Clinical Data Manager at Amgen where she took on roles of increasing responsibility as well as leading multiple continuous improvement projects. She joined AstraZeneca as a Data Management Expert in 2015 then quickly moved into more operations focused roles, leading the setup of a key Clinical Trial Delivery model across Data Management and Statistics/Statistical Programming before gaining additional operational experience in supporting a large clinical data focused department in Business Planning and Operations. In January 2021 she was asked to be the overall Business Programme Lead for the transformational Redefining Clinical Data Flow Programme, which is delivering streamlined data flow and improved system benefits to the company.

      Session Details:

      Case study: Redefining clinical data flow

      2024-06-11, 11:45 AM

      Session Details:

      Fireside Chat: Exploring data management tools and technologies that can assist in clinical trials

      2024-06-11, 3:45 PM

      View In Agenda
      Next speaker
      Back
      Farrell Healion
      Senior Director, Emerging Technology, Global Clinical Solutions, AstraZeneca

      Farrell Healion is currently Senior Director Emerging Technologies, Global Clinical Solutions at AstraZeneca, where he leads the operational readiness delivery to scale up new technologies to be used in their clinical trials. He previously led their Digital Patient Solutions team that deliver patient-facing Digital Health Technologies(DHTs) such as eCOA across the AstraZeneca portfolio.

      Starting out as an eCOA Developer at CRF Health, Farrell then moved through various technical leadership roles eventually leading the Technical and Project Management Office in Signant Health before moving to AstraZeneca. He is passionate about scaling up the use of patient and site-centric new DHTs in Clinical Trials, getting involved with various industry work groups such as DTRA and the eCOA Consortium. He is also the 2023 winner in Pharmatimes International Clinical Researcher of the Year award in the Decentralised Solutions category.

       

      Session Details:

      Implementing digital health technologies into clinical trials

      2024-06-12, 11:45 AM

      View In Agenda
      Next speaker
      Back
      Rachael McTegart
      Contracts and Outsourcing Director, Barinthus Biotherapeutics

      Session Details:

      Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

      2024-06-11, 2:45 PM

      View In Agenda
      Next speaker
      Back
      Alecia Barry
      Alecia Barry, Executive Director, Oncology Clinical Operations, Gilead Sciences

      Alecia Barry, PhD, joined Gilead in 2022 as Clinical Operations Franchise Head for Breast, Gynaecological and Genito-urinary Cancers.   In her current role, Alecia oversees and leads a large group of oncology Clinical Operations professionals with global scope and accountability for operational strategy definition and trial execution to meet cost, speed and quality standards.  Alecia serves a thought partner to the Oncology Clinical Development Franchise Heads providing strategic operational leadership and expertise. She is a member of the Clinical Operations Oncology Leadership Team with responsibilities for developing and evolving short- and long-range Clinical Operations strategies, plans, processes, tools and infrastructure development. Alecia functions as a Clinical Operations Vendor Lead for strategic CRO partnerships, with accountability to develop relationships, identify cross-portfolio issues, elevate to governance committees, and lead effective multi-level engagement and communication with Gilead and with CRO partners.

      Alecia obtained her pharmacy degree, higher diploma in Quality Management and a PhD in Pharmaceutics from Trinity College, University of Dublin.  Alecia has more than 15 years’ experience in the pharmaceutical industry across at various levels and positions in pharmaceutical development and clinical operations.

      Session Details:

      Clinical trial budgeting – is the price right?

      2024-06-12, 11:45 AM

      View In Agenda
      Next speaker
      Back
      Scotty Chung-Siu
      Managing Analyst, Clinical Trials Intelligence, GlobalData

      Session Details:

      Clinical trials: Adoptive cell therapy

      2024-06-12, 12:15 PM

      View In Agenda
      Next speaker
      Back
      Priya Ravisekara
      Senior Analyst, GlobalData

      Priya Ravisekara, MSc,is a senior analyst at GlobalData in London, UK, where her primary responsibilities include producing analytical reports, improving and maintaining database functionality through quality assurance testing, updating and monitoring Global Data’s Clinical Trials Intelligence Database, and answering queries directly from clients. Priya holds a Masters in Clinical Drug Development from Barts and The London School of Medicine and Dentistry, and a Bachelor of Science in Biochemistry from Brunel University, London.​

      Session Details:

      Chairperson’s opening remarks

      2024-06-11, 8:50 AM

      Session Details:

      Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

      2024-06-11, 2:45 PM

      Session Details:

      Panel discussion: Overcoming site start-up delays and maximizing site productivity

      2024-06-11, 3:45 PM

      Session Details:

      Chairperson’s closing remarks

      2024-06-12, 4:30 PM

      Session Details:

      Chairperson’s opening remarks

      2024-06-12, 8:50 AM

      Session Details:

      Chairperson’s closing remarks

      2024-06-11, 4:30 PM

      View In Agenda
      Next speaker
      Back
      Ken Chow
      Health Tech Counsel, Flanders Investment & Trade

      After receiving his scientific trainings in the areas of infectious diseases, oncology, and pharmacology at Institut Pasteur Paris, VU Amsterdam and DUKE-NUS Singapore, Ken started to advise on the R&D (e.g. academic/industry collab., clinical trials, manufacturing, RAs etc), intellectual properties, and investment (buy/sell) partnerships for 100+ small/listed biopharm companies worldwide. These were all thanks to his 10+ years of experience in Brinc, Hong Kong Science Park, an University tech transfer office, and an international patent agency. Currently, Ken is the Health Tech Counsel for the London office of the Government of Flanders. His role is to identify and advise on any biopharm / heath tech-focused collaborations between the ecosystem stakeholders in the UK, Ireland, and the Flanders region of Belgium.

      Session Details:

      Panel Discussion: Innovative thinking for increasing patient diversity and inclusion in clinical trials

      2024-06-12, 12:15 PM

      View In Agenda
      Next speaker
      Back
      Craig Elliott
      Director Alliance Management and Sourcing, Merck

      Craig is Director Alliance Management and Sourcing, with responsibility for Central Labs, Imaging, Phase 1 and Early Access Programs.

      Craig has worked for over 35 years in Clinical Research in both large pharma and small, medium and large CROs and academia performing a number of roles: CRA, line management, quality and training, alliance management, process improvement and strategic improvements. Craig has worked across multiple therapeutic areas and supported business development and operations interacting with large pharmaceutical companies and biotech sponsors.  He has worked on a number of global strategic initiatives.

      Craig is a PhD in Respiratory and Exercise Physiology and a BSc in Physiology and Biology.  He is also a qualified cricket coach.

      Session Details:

      Finding the right balance between the needs of sponsor company and vendor for successful partnerships and oversight

      2024-06-11, 11:45 AM

      Session Details:

      Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

      2024-06-11, 2:45 PM

      View In Agenda
      Next speaker
      Back
      Fiona Shields
      Study and Site Operations Country Head (UK), Novartis

      Fiona is an experienced Clinical research Professional who has 25+ years of extensive experience in different roles of Clinical Trial Operations. Starting her career as an Oncology Nurse she moved into Clinical Research to support the development of Clinical Trial delivery at the Leicester Royal Infirmary which then became part of the National Cancer Research Network. Moving her career forward she has undertaken a variety of roles, in CROs, Pharma and Medical Device companies concentrating on the building of trial Operation Services.

      In her current role,  Country Head ( UK), Study and Site Operations,  within Novartis Fiona is accountable for all country clinical operations and has a responsibility to drive the strategic direction of the study and site operations department. She  manages a team of accomplished leaders to increase the contribution that Novartis can make within the Clinical Trial landscape.

      Throughout her career Fiona has always had a passion for people leadership and applies this in her management and leadership style.

      Session Details:

      Panel discussion: Overcoming site start-up delays and maximizing site productivity

      2024-06-11, 3:45 PM

      View In Agenda
      Next speaker
      Back
      Rebecca Mbewe
      Patient Advocate

      Session Details:

      Fireside Chat: The patient journey when participating in a clinical trial

      2024-06-12, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Ashton Harper
      Head of Medical Affairs, Access & Innovation, Roche

      Session Details:

      Incorporating sustainability in clinical trials to improve ESG responsibilities

      2024-06-11, 12:45 PM

      View In Agenda
      Next speaker
      Back
      James Rudge
      Technical Director, Neoteryx

      Session Details:

      Utilising remote sampling in large studies: examples and key learnings

      2024-06-12, 2:30 PM

      View In Agenda
      Next speaker
      Back
      Nathaniel Scott
      Medical Physicist, Blue Earth Therapeutics

      Nathaniel Scott is a seasoned Clinical Scientist and certified Medical Physics Expert (MPE) specialising in nuclear medicine. Currently with Blue Earth Therapeutics, Nathaniel leads on the scientific aspects of imaging and dosimetry in the clinical development program. Having trained as a Clinical Scientist within in the National Health Service, Nathaniel later transitioned to developing and overseeing a comprehensive nuclear medicine physics service within a private oncology network in the UK. Their expertise lies in radiopharmaceutical therapy and dosimetry, with a drive for improving patient care and treatment effectiveness.

      Session Details:

      ROUNDTABLE SESSIONS

      2024-06-12, 3:30 PM

      View In Agenda
      Next speaker
      Back
      Richard Gray
      Managing Partner, Medidata, Dassault Systemes

      Richard Gray is a Managing Partner at Dassault Life Sciences, engaged across the full portfolio including the market leading Medidata brand. He has been serving the life sciences & healthcare industry for over 30 years, inspired by the opportunity to accelerate productivity across the value chain and improve outcomes for patients.

      With a background in process optimization, data, and technology, he has enabled many European and US sponsors to uplift their capabilities, and in his current role he is driving innovation in areas including early-stage research and discovery, through preclinical and clinical, out to manufacturing, supply chain and commercialisation.

      Richard believes that data [strategy] holds the key to accelerating the value of technology, creating the opportunity to connect physical and digital worlds to advance virtual twin experiences, enabling the promise of AI to be democratized, and fueling in silico approaches that will revolutionise the science of tomorrow.

      Session Details:

      A New Paradigm for Clinical Innovation

      2024-06-11, 10:15 AM

      Session Details:

      Fireside Chat: Exploring data management tools and technologies that can assist in clinical trials

      2024-06-11, 3:45 PM

      View In Agenda
      Next speaker
      Back
      Sevtap Rowlands
      Director of Clinical Operations, 4 Medical Clinical Solutions (4MCS)

      Session Details:

      Panel discussion: Overcoming site start-up delays and maximizing site productivity

      2024-06-11, 3:45 PM

      View In Agenda
      Next speaker
      Back
      Julie Hepburn
      Patient Representative Lead PPI&E, Cardiff ECMC and Advanced Therapies Wales

      Session Details:

      Case study: Utilising academic and industry collaborations for PPI in clinical trials

      2024-06-12, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Sarah Tissington
      Regional Director, Clinical Site Management & Monitoring EU/UK, Moderna

      Session Details:

      Panel Discussion: Innovative thinking for increasing patient diversity and inclusion in clinical trials

      2024-06-12, 12:15 PM

      View In Agenda
      Next speaker
      Back
      Leonie Martin
      Senior Director, Clinical Operations, Orchard Therapeutics

      Session Details:

      Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

      2024-06-11, 2:45 PM

      View In Agenda
      Next speaker
      Back
      Mihad Mohamed
      Product Director – Research and Life Sciences, EMIS

      Mihad is a Product Director for research and life sciences at EMIS. He has spent the last 10 years leading the dvelopment of data driven products for the clinical trials sector. Working with leading academic and commercial research organisations, he managed the development of a suite of data driven products on the EMIS-X Analytics platform. Prior to joining EMIS, he played a pivotal role in developing various modules within the Medidata Clinical Trial Management System (CTMS) catering to global study teams and sites.

      Session Details:

      Partnering with primary care to maximise study site potential

      2024-06-11, 10:45 AM

      View In Agenda
      Next speaker
      Back
      Josep Bori
      Research Director, Thematics Division, GlobalData

      Session Details:

      Artificial Intelligence in Pharma

      2024-06-11, 12:45 PM

      View In Agenda
      Next speaker
      Back
      Shilpa Muthusamy
      Principle Investigator and Site Director, Velocity Clinical Research

      Shilpa is a Principle Investigator and Site Director at Velocity Clinical Research with over 8 years of physician experience. She is passionate about diversity and inclusion of ethnic minorities within clinical trials, and hope that by leading Velocity's new trial site in Romford we can improve trial access for this population. Shilpa is committed to achieving this goal which will allow us to have a better understanding of the chronic disease burden in this population and develop more targeted therapies in the future.

      Session Details:

      Panel Discussion: Innovative thinking for increasing patient diversity and inclusion in clinical trials

      2024-06-12, 12:15 PM

      View In Agenda
      Next speaker
      Back
      Evelyne Newton
      Vice President of Business Development, Velocity Clinical Research

      With over 20 years of experience in the healthcare and clinical research sector, Evelyne is a Vice President of Business Development at Velocity Clinical Research, Inc. She leads key strategic partnerships globally and drive sales in Europe. She is committed to partnering with CROs/Sponsors to deliver high-quality clinical trial data and patient care with unprecedented efficiency.  She is also passionate about diversity, equity, inclusion, and belonging (DEIB), she serves as a co-chair of the DEIB Council at Worldwide Clinical Trials. In this capacity, Evelyne collaborates with other leaders and stakeholders to foster a culture of respect, empowerment, and belonging across the organization. Her mission is to contribute to the advancement of healthcare and clinical research.

      Session Details:

      Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

      2024-06-11, 2:45 PM

      View In Agenda
      Next speaker
      Back
      Yooni Kim
      Vice President Clinical Services, Novotech

      Yooni Kim is the Global Head of Clinical Services at Novotech with over 24 years of clinical research experience and technical knowledge in CRO, Pharmaceutical Company and Academy Research Institution. With a Ph.D. in Preventive Medicine (Epidemiology) from the Seoul National University of Medicine, she started her career at GSK in 2004 and joined ICON Clinical Research (ex-PRA) in 2009 as Director of Operations. Yooni worked with PRA Health Sciences for 7 years, establishing the legal entity and service capabilities for PRA Korea. Since joining Novotech in 2016, she served as the Executive Director Asia Operations. Currently, she continues to lead Global Clinical Operations at Novotech.

      Session Details:

      Unlocking APAC potential to enhance your Clinical Trial Program

      2024-06-11, 2:15 PM

      View In Agenda
      Next speaker
      Back
      Sverre Bengtsson
      Co-Founder, Viedoc

      Sverre Bengtsson started in the clinical trials industry over 30 years ago. He started as a statistician/statistical programmer, later into data management and since over 20 years into business development. He has been working in both CRO’s as well as in clinical trials technology companies, including the global first ePRO company. Sverre is very interested in making clinical trials efficient, in both study design but also in the processes and technologies used. Sverre co-founded Viedoc Technologies 19 years ago and is responsible for some of the major accounts but also the vision around the company. He’s on the board of both some industry organisations and in clinical technology companies.

      Session Details:

      A 360° view of digitalization in clinical trials

      2024-06-11, 12:15 PM

      View In Agenda
      Next speaker
      Back
      Davy Yeung
      COO, TCR-Solutions

      Dr Davy Yeung’s career to date encompasses academia and the NHS. He has made valuable contributions to clinical research at the University of Cambridge, Imperial College, and other major academic institutions.

      Dr Yeung was also the Head of Research at various UK Hospital Trusts. During his time in the NHS, he gained considerable insight into the governance and delivery of clinical research in the UK. This unique perspective enables our sponsors to select, initiate and manage UK investigative sites for their clinical studies rapidly and effectively. Having collaborated with a wide range of influential leaders in the field of clinical research, Dr Yeung is himself highly respected and well known in the UK’s healthcare research and development sector.

      Session Details:

      Re-defining the sponsor and hospital site relationship in 2024

      2024-06-11, 12:15 PM

      View In Agenda
      Next speaker
      Back
      Michael Lewis
      Professor of Life Science Innovation, University of Birmingham and Scientific Director Innovation, NIHR

      Session Details:

      Keynote: Latest overview of UK clinical trial landscape: are we achieving the ambition?

      2024-06-11, 9:00 AM

      Session Details:

      Panel discussion and audience Q&A: Reviewing recent improvements to UK clinical trial landscape and future actions for continued success

      2024-06-11, 9:30 AM

      View In Agenda
      Next speaker
      Back
      Duncan Hall
      Chief Executive Officer, TRI

      Session Details:

      How RBQM creates trust between sponsors and CROs

      2024-06-12, 9:30 AM

      View In Agenda
      Next speaker
      Back
      Bruce Hellman
      Co-Founder and Chief Patient Officer, UMotif

      Chief Patient Officer and Co-Founder - uMotif

      Bruce is the Chief Patient Officer of uMotif and co-founded the company in 2012. He and his team have designed and built a patient-centric eCOA / ePRO data capture platform for clinical and real-world research.

      Bruce began his career working in clinical trials at British Biotech before joining the UK Civil Service Fast Stream in the Department for Culture, Media and Sport. Prior to founding uMotif, Bruce worked at Serco and completed an Executive MBA from Imperial College Business School.

      Bruce has been recognized in the PharmaVoice 100 as one of the most innovative entrepreneurs in life sciences and has also been nominated as one of Computer Weekly's UKtech50 Rising Stars, won the Cisco BIG awards, and was nominated by Real Business magazine as one of the '30 to watch in mobile'.

       

      Bruce is a 3-time Ironman finisher and Head Coach of the Teddington Athletic Under 11s Sharks football team.

      Session Details:

      Putting patients at the centre of their clinical trial journey: supporting engagement, driving ePRO compliance

      2024-06-11, 2:15 PM

      View In Agenda
      Next speaker
      Back
      Helen Shaw
      Head of Clinical Operations and Co-Founder, VCTC

      Helen Shaw, PhD, is the Co-founder and Head of Clinical Operations of VCTC, a patient-centric clinical trial site dedicated to bringing clinical research directly to participants through compassionate and expedited site processes. Dr. Shaw holds a PhD with a focus in clinical trial methodology, from the University of Birmingham, where she developed early considerations for the use of eConsent in clinical trials. During her 15+ years serving in the industry—including in her current role as Head of Clinical Operations at VCTC—Dr. Shaw has advocated for, and participated in, the development and implementation of strategies that make clinical research more accessible and less burdensome for participants.

      Session Details:

      An evolution of the clinical trial site

      2024-06-12, 10:30 AM

      View In Agenda
      Next speaker

      Plan Your Visit

      Venue

      London Hilton on Park Lane

      22 Park Lane W1K 1BE London United Kingdom

      Book Your Stay

      Accommodation

      Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. For the avoidance of doubt, Arena will only share attendee lists with carefully selected third party partners for event registration purposes. Whilst Arena International Events Group pursues third party agencies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.

      Sponsors

      Select a sponsor to learn more

      FEATURED SPONSORS

      SESSION SPONSORS

      EXHIBITORS

      CO-SPONSORS

      Why partner?

      Contact us to become a partner

      Partnership Opportunities

      We work with you to design a bespoke package to meet your business needs, where you could:

      • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
      • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
        Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
      • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

      Event reach

      • 200+ attendees each year
      • 80% attendees C-suite level

       

      Take a look at our current sponsors

      Resources

             
             
         

      Media Centre

      Media Partners

      Become A Media Partner

      See What It's All About

      Enquiry

      Contact Us

      SPONSORSHIP ENQUIRIES

      Ben Lloyd-Davis

      Head of Healthcare Sponsorship

      +44 207866 9497

      SPEAKING OPPORTUNITIES

      Ruth Atterbury

      CTS Portfolio Manager

      MARKETING ENQUIRIES

      Moona Popal

      Marketing Manager

      DELEGATE ENQUIRIES

      Sunny Saikia

      VIP Delegate Manager

      SPONSORSHIP ENQUIRIES

      To enquire about sponsorship opportunities for the conference, please contact:

      Ben Lloyd-Davis

      Head of Healthcare Sponsorship


      +44 207866 9497

      SPEAKER ENQUIRIES

      To enquire about speaking opportunities for the conference, please contact:

      Ruth Atterbury

      CTS Portfolio Manager